Qingdao Haier Biomedical Co Ltd (688139) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Qingdao Haier Biomedical Co Ltd (688139) has a cash flow conversion efficiency ratio of 0.002x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥7.33 Million ≈ $1.07 Million USD) by net assets (CN¥4.34 Billion ≈ $634.47 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 688139 company net worth for the company's overall valuation and market capitalisation.
Qingdao Haier Biomedical Co Ltd - Cash Flow Conversion Efficiency Trend (2016–2025)
This chart illustrates how Qingdao Haier Biomedical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Qingdao Haier Biomedical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Qingdao Haier Biomedical Co Ltd ranked by their cash flow conversion efficiency. Explore how high is Qingdao Haier Biomedical Co Ltd's earnings quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Focus Technology Co Ltd
SHE:002315
|
0.169x |
|
Henan Hanwei Electronics Co
SHE:300007
|
-0.020x |
|
Telecom Argentina SA ADR
NYSE:TEO
|
0.106x |
|
MicroPort Scientific Corporation
F:MSK
|
-0.055x |
|
Hunan Oil Pump
SHG:603319
|
0.018x |
|
TGS ASA SP.ADR/1
F:TGC0
|
0.129x |
|
Pearl Abyss Corp
KQ:263750
|
0.017x |
|
Triangle Tyre Co Ltd
SHG:601163
|
0.013x |
Annual Cash Flow Conversion Efficiency for Qingdao Haier Biomedical Co Ltd (2016–2025)
The table below shows the annual cash flow conversion efficiency of Qingdao Haier Biomedical Co Ltd from 2016 to 2025. View Qingdao Haier Biomedical Co Ltd (688139) stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥4.62 Billion ≈ $676.52 Million |
CN¥267.89 Million ≈ $39.20 Million |
0.058x | -8.25% |
| 2024-12-31 | CN¥4.62 Billion ≈ $675.78 Million |
CN¥291.67 Million ≈ $42.68 Million |
0.063x | +12.50% |
| 2023-12-31 | CN¥4.44 Billion ≈ $649.71 Million |
CN¥249.26 Million ≈ $36.48 Million |
0.056x | -63.17% |
| 2022-12-31 | CN¥4.15 Billion ≈ $607.03 Million |
CN¥632.43 Million ≈ $92.54 Million |
0.152x | -12.28% |
| 2021-12-31 | CN¥3.64 Billion ≈ $532.46 Million |
CN¥632.43 Million ≈ $92.54 Million |
0.174x | -30.53% |
| 2020-12-31 | CN¥2.78 Billion ≈ $407.46 Million |
CN¥696.62 Million ≈ $101.94 Million |
0.250x | +119.32% |
| 2019-12-31 | CN¥2.46 Billion ≈ $359.82 Million |
CN¥280.49 Million ≈ $41.04 Million |
0.114x | -14.74% |
| 2018-12-31 | CN¥1.11 Billion ≈ $162.98 Million |
CN¥149.00 Million ≈ $21.80 Million |
0.134x | -44.55% |
| 2017-12-31 | CN¥614.76 Million ≈ $89.96 Million |
CN¥148.32 Million ≈ $21.70 Million |
0.241x | -20.99% |
| 2016-12-31 | CN¥722.81 Million ≈ $105.77 Million |
CN¥220.72 Million ≈ $32.30 Million |
0.305x | -- |
About Qingdao Haier Biomedical Co Ltd
Qingdao Haier Biomedical Co.,Ltd engages in the research and development, manufacture, marketing, and sale of low temperature storage equipment for biomedical samples in China and internationally. The company offers ULT freezers, pharmacy refrigerators, freezers, automatic storage solutions, cryogenics, active temperature controlled RKN containers, and RTMD products; and CO2 incubation, standard … Read more